Plant production systems for vaccines

Expert Review of Vaccines

Volumn 2, Issue 6, 2003, Pages 763-775

  Streatfield, Stephen J ^a   Howard, John A ^a  

^a Prodigene Inc   (United States)

Author keywords

Adjuvants; Animal vaccines; Clinical trials; Cold chain; Corn; Oral vaccines; Production cost; Scale up; Subunit vaccine; Transgenic plants

Indexed keywords

BACTERIAL ANTIGEN; CAPSID PROTEIN; ENTEROTOXIN; HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; VACCINE; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL DISEASE; ANTIGEN PRESENTATION; ANTIGEN PURIFICATION; CELLULAR IMMUNITY; CEREAL; CHLOROPLAST; GRAIN; HEPATITIS B; HUMAN; HYDROPONICS; IMMUNOGENICITY; MALARIA; MALTING; NONHUMAN; PLANT CELL CULTURE; PLANT PRODUCT; PLANT TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; REVIEW; TRANSGENIC PLANT; VACCINE PRODUCTION; VIRUS INFECTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; BIOREACTORS; HUMANS; PLANTS, EDIBLE; TECHNOLOGY, PHARMACEUTICAL; VACCINATION; VACCINES, EDIBLE; VACCINES, SUBUNIT;

EID: 0347480273     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.2.6.763     Document Type: Review

References (50)

1. Kusnadi AR, Nikolov ZL, Howard JA. Production of recombinant proteins in transgenic plants: practical considerations. Biotechnol. Bioeng. 56, 473-484 (1997). Overviews practical considerations for large-scale production.
2. Jilka JM, Hood EE, Dose R, Howard JA. The benefits of proteins produced in transgenic plants. Ag. Biotech. Net. (1) Abstract 27 (1999). Compares cost models for rival production systems.
3. Daniell H, Streatfield SJ, Wycoff K. Medical molecular farming: production of antibodies, edible vaccines and biopharmaceuticals in plants. Trends Plant Sci. 6, 219-226 (2001).
4. Zhong GY, Peterson D, Delaney DE et al. Commercial production of aprotinin in transgenic maize seeds. Mol. Breed. 5, 345-356 (1999).
5. Iyer LM, Kumpada SP, Chandrasekharan MB, Hall TC. Transgene silencing in monocots. Plant Mol. Biol. 43, 323-346 (2000).
6. Streatfield SJ, Howard JA. Plant-based vaccines. Int. J. Parasitol. 33, 479-493 (2003). A recent detailed review of plant-based vaccines with many research examples.
7. Chikwamba R, McMurray J, Shou H et al. Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) in maize. Mol. Breed. 10, 253-265 (2002).
8. Streatfield SJ, Lane JR, Brooks CA et al. Corn as a production system for human and animal vaccines. Vaccine 21, 812-815 (2003).
9. Lerouge R, Cabanes-Macheteau M, Rayon C et al. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 38, 31-48 (1998).
10. Fischer R, Liao YC, Drossard J. Affinity purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture. J. Immunol. Methods 226, 1-10 (1999).
11. Torres E, Vaquero C, Nicholson L et al. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res. 8, 441-449 (1999).
12. Botterman J, Leemans J. Engineering herbicide resistance in plants. Trends Genet. 4, 219-222 (1988).
13. Estruch JJ, Carozzi NB, Desai N et al. Transgenic plants: an emerging approach to pest control. Nat. Biotechnol. 15, 1324 (1997).
14. Streafield SJ, Mayor JM, Barker DK et al. 2000 congress symposium on molecular farming: development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell Dev. Biol.-Plant 38, 11-17 (2002). Explores a practical oral delivery option for humans.
15. Borisjuk NV, Borisjuk LG, Logendra S et al. Production of recombinant proteins in plant root exudates. Nat. Biotechnol. 17, 466-469 (1999).
16. Rodriguez, RL. Process for protein production in plants. US5889189, March 30, 1999.
17. Daniell H, Khan MS, Allison L Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 7, 84-91 (2002). Overviews a rapidly developing technology for protein production in plants.
18. Dalsgaard K, Uttenthal A, Jones TD et al. Plant-derived vaccine protects target animals against a viral disease. Nat. Biotechnol. 15, 248-252 (1997).
19. Joelson T, Akerblom L, Oxelfelt P et al. Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J. Gen. Virol. 78, 1213-1217 (1997).
20. Yusibov V, Modelska A, Steplewski K et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl Acad. Sci. USA 94, 5784-5788 (1997).
21. Wigdorovitz A, Perez Filgueira DM, Robertson N et al. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic vurus expressing the FMDV structural protein VP1. Virology 264, 85-91 (1999).
22. O'Brien GJ, Bryant CJ, Voogd C et al. Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles. Virology 270, 444-453 (2000).
23. Zhang G, Leung C, Murdin L, Rovinski B, White KA. In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector. Mol. Biotechnol. 14, 99-107 (2000).
24. Kusnadi AR, Hood EE, Witcher DR, Howard JA, Nikolov ZL. Production and purification of two recombinant proteins from transgenic com. Biotechnol. Prog. 14, 149-155 (1998).
25. Woodard SL, Mayor JM, Bailey MR et al. Maize-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol. Appl. Biochem. 37, 1-8 (2003). Describes the large-scale protein product made in recombinant plants.
26. Lamphear BJ, Streatfield SJ, Jilka JM et al. Delivery of subunit vaccines in maize seed. J. Control. Release 85, 169-180 (2002). Demonstrates protective efficacy for an animal vaccine candidate and addresses product stability.
27. Guilley H, Dudley RK, Jonard G, Balazs E, Richards KE. Transcription of cauliflower mosaic virus DNA. detection of promoter sequences, and characterization of transcripts. Cell 30, 763-773, 37, 1-8, (1982).
28. Christensen AH, Sharrock RA, Quail PH. Maize polyubiquitin genes: structure, thermal perturbation of expression and transcript splicing, and promoter activity following transfer to protoplasts by electroporation. Plant Mol. Biol. 18, 675-689 (1992).
29. Breyne P, van Montagu M, Depicker N, Gheysen G. Characterization of a plant scaffold attachment region in a DNA fragment that normalizes transgene expression in tobacco. Plant Cell 4, 463-471 (1992).
30. Yang D, Wu L, Hwang YS, Chen L, Huang N. Expression of the REB transcriptional activator in rice grains improves the yield of recombinant proteins whose genes are controlled by a Reb-responsive promoter. Proc. Natl. Acad. Sci. USA 98, 11438-11443 (2001).
31. Richter, LJ, Thanavala Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Natl Biotechnol. 18, 1167-1171 (2000).
32. Daniell H, Lee SB, Panchai T, Wiebe PO. Expression of the native cholera toxin B subunit gene and assembly of functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311, 1001-1009 (2001).
33. Dus Santos MJ, Wigdorovitz A, Trono K et al. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20, 1141-1147 (2002).
34. Hood EE, Bailey MR, Beifuss K et al. Criteria for high-level expression of a fungal laccase gene in transgenic maize. Plant Biotecbnol. J. 1, 129-140 (2003).
35. Streatfield SJ, Jilka JM, Hood EE et al. Plant-based vaccines: unique advantages. Vaccine 19, 2742-2748 (2001).
36. Arakawa T, Chong DKX, Merritt JL, Langridge WHR. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. 6, 403-413 (1997).
37. Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268, 714-716 (1995).
38. McGarvey PB, Hammond J, Dienelt MM et al. Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology 13, 1484-1487.
39. Wenderoth I, von Schaewen A. Isolation and characterization of plant N-acetyl glucosaminyltansferase I (GntI) cDMA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. Plant Physiol. 123, 1097-1108 (2000).
40. Bakker H, Bardor M, Molthoff JW et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl Acad. Sci. USA 98, 2899-2904 (2001).
41. Jackson S, Mestecky J, Childers NK, Michalek SM. Liposomes containing anti idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect. Immun. 58, 1932-1936 (1990)
42. Arakawa T, Chong DKX, Langridge WHR. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotechnol. 16, 292-297 (1998).
43. Mason HS, Haq TA, Clements JD, Arntzen, CJ. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16, 1336-1343 (1998).
44. Tacket CO, Mason HS, Losonsky G et al. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4, 607-609 (1998). Report of a human clinical trial.
45. Tacket CO, Mason HS, Losonsky G et al. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182, 302-305 (2000). Report of a human clinical trial.
46. Yu J, Langridge WHR. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 19, 548-552 (2001). A more detailed analysis of immune responses.
47. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl Acad. Sci. USA 98, 11539-11544 (2001).
48. Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res. 11, 479-493 (2002).
49. Kapusta J, Modelska A, Pniewski T et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796-1799 (1999). Report of a human clinical trial.
50. Yusibov V, Hooper DC, Spitsin SV et al. Expression in plants and inimunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20, 3155-3164 (2002). Report of a human clinical trial.